Lirametostat (CPI-1205)
Products
Description
Lirametostat (CPI-1205) is an orally available selective inhibitor of the histone lysine methyltransferase EZH2 with IC50 values of 2 nM and 52 nM for EZH2 and EZH1 respectively. It has potential antineoplastic activity.
Specifications
| Manufacturer Cat# | S8353 |
|---|---|
| Target | Histone Methyltransferase |